eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Head & Neck Surgery

Monitors, Facial Nerve

Author: Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development
Contributor Information and Disclosures

Updated: Jan 20, 2010

Introduction

Facial nerve injury is a devastating surgical complication. It can produce grotesque alteration of facial appearance, expose the eye to vision-threatening desiccation and infection, and impair competence of the oral sphincter, resulting in drooling and alterations in vocal quality.

Individuals who have had severe facial nerve injury experience degraded self-image and loss of self-confidence and self-esteem. Most experience at least transient depression. Both social interaction and occupational status can be affected.

The surgical anatomy and landmarks of the facial ...

The surgical anatomy and landmarks of the facial nerve.

The surgical anatomy and landmarks of the facial ...

The surgical anatomy and landmarks of the facial nerve.


Many occupations cannot be successfully pursued with distorted facial features. Newscasters, actors, and other public personalities are obvious examples, although people in sales and public service positions may also find achieving occupational success more difficult because of facial distortion that is off-putting to potential clients and customers. Facial paralysis therefore can have a disastrous effect not only on socialization but also on career and income.

Consequently, surgeons who operate in the anatomic areas traversed by the facial nerve welcome and accept any adjunctive technique that potentially reduces the incidence of facial paralysis. Intraoperative facial nerve monitoring has resulted in objectively demonstrable improvement in facial nerve outcome for patients undergoing posterior fossa surgery for tumor removal. Few surgeons would remove an acoustic neuroma without a functioning facial nerve monitor, but objective documentation of improved results in mastoid and middle ear surgery is not yet forthcoming. Nonetheless, despite the absence of objective data, many surgeons are convinced that the facial nerve monitor is helpful for otologic surgery and regularly use it for routine otologic operations.1,2

The facial nerve can be injured by direct mechanical disruption from a rotating burr, transection with a sharp instrument, accidental evulsion (eg, from traction), or crushing injury. A rotating surgical burr can produce thermal injury without directly contacting the facial nerve. Thermal injury is more likely when diamond burrs are used than when cutting burrs are used.

Facial nerve monitoring is not a panacea, and it does not substitute for anatomic knowledge. As Prass stated in 1996, "Improper set up, equipment failure, or misuse may lead to worse outcomes than if facial monitoring was not used."3

Consequently, all surgeons who use this technology must understand the principles that underlie it and must become thoroughly familiar with its use.

Physiology

Some enthusiasm was evident in the early 1980s for mechanical monitoring techniques that relied on sensing actual facial movement. These techniques have fallen into disfavor, principally because actual movement requires a large suprathreshold response; consequently, mechanical techniques are less sensitive to facial nerve stimulation than are electrophysiologic techniques. Only a few surgeons continue to use them.

In 1979, Delgado became the first person to use electrophysiologic monitoring of the facial nerve. He used evoked electromyography and monitored the electromyographic responses, as is generally practiced today.

Electromyography depends on noting the difference in electrical potential that occurs within the muscle associated with a depolarizing current. As the electrical potential moves past the first of the 2 paired electrodes, that electrode becomes negative with respect to the second. As the wave reaches the second electrode, a deflection in the opposite direction occurs. The electromyographic electrical response is biphasic, ie, it has both positive and negative components.4,5

As a practical matter, neurophysiologic monitoring of the facial nerve continuously evaluates the electromyographic activity in the monitored facial muscles. Both a graphic signal, which can be observed on an oscilloscope screen, and an acoustic signal, which can be heard throughout the operating theatre, are generated. Prass has distinguished between 2 types of potential responses.6,3

Repetitive responses

Repetitive responses occur as a result of repetitive depolarizations that follow the cessation of surgical manipulation. Such responses may indicate increased irritability as a result of injury. They sometimes are referred to as "training". They cannot be used to locate the nerve but can warn the operating surgeon that injury has occurred or is imminent. Repetitive responses can occur as a result of thermal stimulation, trauma, or traction. Occasionally, cold irrigation alone suffices to produce brief trains of repetitive responses.

Nonrepetitive responses

Nonrepetitive responses are produced by direct mechanical or electrical stimulation of the facial nerve and occur in close temporal association with the stimulus. These nonrepetitive responses are much more important in defining the boundaries of the nerve. Because they are single responses that are directly associated with the stimulus, nonrepetitive responses allow the surgeon to locate the edge of the nerve and to map its anatomic contour.

Experienced surgeons who have used facial nerve monitors for many years agree that the significance of evoked electromyography can be assessed only within the context of the surgical events that occur during the response.7

Safety

Occasionally, questions about the safety of facial nerve monitoring have been raised, including the following:

  • Does repetitive intraoperative stimulation injure the nerve?
  • Can frequently repeated stimulation produce metabolic exhaustion (a permanent injury)?
  • Are low-stimulation intensities safer than high-stimulation intensities?

To address such questions, in 1980, Hughes et al utilized a mouse sciatic nerve model to examine both pulsed and direct current stimuli.8 A pulsed current produced no evidence of injury. Direct current produced some mild injury and, occasionally, axonal degeneration. Virtually all available monitors use a pulsed current technology.

Also in 1980, Babin et al developed a cat facial nerve model to assess the safety of continuous facial nerve stimulation.9 They applied 3 stimulations per second to the cat facial nerve at 1 milliampere (mA) for 1 hour. The nerve had no permanent changes in sensitivity, although a transient decrease in sensitivity occurred for several minutes after cessation of stimulation.

Especially during the last decade, many thousands of patients have been monitored using electrophysiologic techniques, including intraoperative stimulation. This wide clinical experience has not produced any evidence that nerve monitoring can be harmful.

Equipment setup

Several variables can be selected when setting up facial nerve monitoring. Some can be changed during the operation, although others cannot be changed. In 1999, Selesnick pointed out that reports indicate no standardization across the following variables:10

  • Pulse duration
    • The actual charge transmitted to the nerve is the product of the amount of current times the duration over which the current is delivered. Consequently, a pulse duration of 100 microseconds delivers twice the amount of charge than does a pulse deviator of 50 microseconds, assuming a constant current.
    • The default setting for most physiologic monitors is 100 microseconds. Selesnick has shown that 50 microseconds provides a more sensitive stimulus.
    • Some surgeons use a pulse duration of 200 microseconds.
  • Monopolar versus bipolar stimulation
    • When a monopolar probe is used, the current flows from the stimulation probe in all directions. Whether a response is obtained depends on the distance of the nerve from the tip of the probe, the impedance of the tissue between the tip of the probe and the nerve, and the strength of the stimulus.
    • Bipolar stimulation allows current flow only from one tip directly to the other; therefore, the facial nerve is stimulated only if it lies directly between the 2 tips.
    • Bipolar stimulation is more precise because less opportunity exists for shunting of current away from the site of stimulation. However, it is much more prone to false-negative results because no stimulation occurs unless the nerve lies directly in the current's path.
    • Monopolar stimulation is more common than bipolar, but both techniques are used.
  • Constant current versus constant voltage
    • Ohm law indicates that if constant voltage stimulation is used, voltage increases to compensate for current shunting.
    • In a 1985 study, Prass did not detect any difference between constant voltage and constant current systems in either efficacy or safety.6 Nonetheless, constant current systems are used more commonly.
  • Stimulus intensity
    • Stimulus intensity is variable on most commercially available facial nerve monitors and must be adjusted by the operating surgeon. The appropriate stimulus intensity may vary considerably. Unless injured, the unsheathed facial nerve in the subarachnoid space reliably responds to a stimulus intensity as low as 0.05 mA, although the sheathed facial nerve in the mastoid segment often does not respond to stimulus intensities less than 0.15 mA. The operating surgeon must be familiar with this variability.
    • Using an inappropriate setting can be highly misleading. If a stimulus setting of 0.2 mA is used within the internal auditory canal, almost everything the probe touches is likely to result in a facial nerve response. Consequently, this setting would not help identify, isolate, and map the course of the facial nerve.
    • On the other hand, direct stimulation on the sheath of the facial nerve, using a stimulus intensity of 0.05 mA in the mastoid does not generally produce a response. If the operating surgeon is not aware of these differences, he or she might transect a normal facial nerve in the mastoid.
  • Threshold
    • The threshold at which the monitor produces an audible response can be set for most facial nerve monitors and is generally set at 100 microvolts. While varying the threshold setting is possible, it is generally held constant at this level.
    • The threshold setting may be altered if prognostic information about facial nerve recovery is sought at the end of the procedure.

Clinical Application - Electrode Placement

Electrode placement

Paired electrodes are placed in 2 facial muscle groups. The portion of the electrode not within the muscle itself should be insulated. The orbicularis oris and the orbicularis oculi are usually selected. No known topographic organization of the facial nerve exists, either intratemporally or within its extratemporal portions; accordingly, a single lead theoretically suffices. Two separate muscles are usually monitored, principally to assure redundancy. They are relatively large facial muscles and are easily identified.

Commercial electrodes are available from a variety of manufacturers. The electrode leads must not touch each other but must not be too far apart. Some systems are self-checking and alert the surgeon to inadequate electrode placement.

A ground electrode for the intramuscular electrodes and a special remote ground electrode for the stimulation probe must be placed. Thus, a total of 6 electrodes are placed. Each electrode must be correctly connected to the facial nerve monitor.

Once all the electrodes are properly positioned and placed, tapping gently on the face to determine whether a faint response can be heard from the facial nerve monitor is useful. A response indicates that the system is functioning properly.

Monitoring

The amount of electromyographic feedback that can be expected during a given operative procedure depends on the following variables:

  • The adequacy of intramuscular electrode placement
  • The number of independent EMG channels
  • The effectiveness of nerve stimulation
  • The level of nerve irritability
  • The conduction status of the nerve distal to the point of stimulation

In 1994, Silverstein pointed out that a conduction block in the distal portion of the nerve causes a loss in the monitoring value of the facial nerve monitor proximal to that point.11 Prass therefore suggests that, when possible, dissection should proceed from proximal to distal, so that a fresh nerve distal to the area of dissection transmits a stimulated impulse.

The facial nerve monitor can then be used during the course of dissection for the following purposes:

  • To identify the facial nerve
  • To map its contour
  • To identify potential injurious stimuli
  • To obtain prognostic information about postoperative facial nerve function

The facial nerve can be identified on the basis of spontaneous activation of the facial nerve monitor due to mechanical stimuli (eg, traction, compression, abrasion). Generally speaking, such mechanical stimuli occur when the surgeon deliberately manipulates the nerve or tissues around the nerve or touches some portion of the nerve with a dissecting tool.

Surgeons must recognize that the facial monitor cannot be relied upon to invariably identify the nerve prior to serious injury. The information provided by facial nerve monitoring must be used to help interpret information gained by the operating surgeon during the ongoing course of the dissection. Severely injuring or transecting the facial nerve with no warning is possible. Such silent transections have frequently been reported.

The second method by which the facial nerve can be identified is the use of the stimulating tip or probe. Most stimulating probes now have a tip that follows Kartush's design recommendations, ie, the tip is insulated flush to the flat stimulating surface of the probe. This minimizes current shunting. Low-impedance materials, such as spinal fluid, blood, and irrigation fluid, can divert current from the stimulating tip of the probe. The operating surgeon must always keep this caveat in mind. When possible, fluid should be aspirated away from the site of stimulation so that the tip can encounter the nerve in a relatively dry field. This minimizes false-negative responses.

Once the nerve is identified, the facial nerve monitor can be used to map its course. Some surgeons prefer to use a bipolar tip for this purpose in areas where important structures are small and in close proximity. The bipolar tip provides much more precise information about the exact anatomic location of the edge of the nerve; however, it is prone to false-negative results. As a general rule, using the stimulating probe to confirm a visual identification of the facial nerve is best. The use of the facial nerve monitor to map the facial nerve in the absence of its visual identification is fraught with hazard and is unreliable.

Ashram et al point out that stimulation of the nervus intermedius can result in a long-latency, low-altitude response recorded only in the orbicularis oris channel.12 The nervus intermedius lies in an entirely different position from the main trunk of the facial nerve. The operating surgeon must be aware of this potential pitfall in intraoperative facial nerve monitoring and should be aware of whether both the orbicularis oris and the orbicularis oculi channels are activated with intraoperative stimulation.

The monitor can be used to determine that certain types of surgical manipulations are potentially injurious to the nerve. Tugging, torsion of the nerve, or scraping tumor from the nerve may result in facial nerve stimulations, thus indicating to the surgeon that what he or she is doing might result in facial nerve injury. The surgeon can adjust the technique accordingly. The ability to alter technique in response to the facial nerve monitor may be the principal reason the facial nerve monitor produces improved outcomes in posterior fossa surgery.

At the end of the surgical procedure, the facial nerve monitor can be used to assess the likelihood of postoperative facial nerve weakness. Two principle variables have been used to make this determination—determination of the size of the stimulated compound action potential and the nerve's stimulus threshold near the brain stem.

The size of the compound action potential is the less frequently used variable. Its magnitude depends critically on electrode placement. Consequently, consistent electrode placement is required if the sizes of the compound action potentials are to be compared between individuals. Such constancy of electrode placement is difficult to maintain. Various authors have indicated that a compound action potential at the end of the procedure that exceeds 500-800 microvolts indicates a high likelihood of a House-Brackman (HB) I or II facial nerve outcome. The incidence of permanent facial weakness increases as the amplitude of the compound action potential drops below 500 microvolts.

The maximum compound facial nerve amplitude at the end of the procedure depends somewhat on stimulus intensity. For lower-stimulus intensities, the amplitude of the compound action potential varies as stimulus intensity increases. In 1998, Sobottka demonstrated that this effect plateaus with a stimulus intensity of 0.4 mA.13 Consequently, if postdissection amplitude is used as a prognostic indicator, the stimulus intensity should be set to at least 0.4 mA. Using this technique, Sobottka has shown that 15 of 16 individuals whose compound electromyographic amplitude is more than 800 microvolts in response to proximal stimulation of the nerve have HB nerve outcomes of I or II.13

The more commonly used method of prognosticating postoperative facial nerve outcome is to determine the threshold stimulus intensity required to generate a detectable response. Articles in the literature have identified several different breakpoints. As Prass has pointed out, some of the variability may be due to the use of different stimulus durations.

Sobottka demonstrated that 16 of 16 individuals who required more than 0.3 mA to stimulate the proximal facial nerve (around the brain stem) have HB postoperative facial nerve outcomes of III-V.13 Conversely, if the stimulus intensity required to produce a response was less than 0.3 mA, 19 of 22 individuals had HB I or II outcomes. Presade has shown that mean stimulus thresholds at the brain stem of 0.1 mA correlate with HB I and II and that 0.725 mA is the typical stimulus intensity for HBs III-VI.

Selesnick has shown the following correlations at 1-year postoperative follow-up for a large number of patients who had cerebellopontine angle surgery with HB I or II facial nerve outcomes:10

  • Stimulus intensity of 0.1 mA - 90%
  • Stimulus intensity of 0.2 mA - 58%
  • Stimulus intensity of 0.3 mA - 41%

These researchers evaluated their data in several different ways and determined that the statistically important breakpoint is 0.2 mA for a P value of 0.01. In their study, a 0.2-mA threshold had a P value of 0.01.

Nonetheless, recognizing that almost half of the subjects with poor intraoperative electrophysiologic results had good long-term outcomes is important. Consequently, although good electrophysiologic data are very helpful in reassuring patients postoperatively, poor electrophysiologic data do not appear to be reliable enough for use in planning postoperative facial nerve reanimation procedures. In other words, a stimulus threshold of 0.3 mA at the end of the procedure is not sufficiently reliable to allow a direct move to facial nerve reanimation procedures within the first several postoperative months.

Bozord Grayeli has demonstrated that facial nerve outcome can be more reliably prognosticated with simulation intensities of less than 0.05 mA.14 At day 8, HB I/VI or II/VI function was observed in 93% of patients with stimulus thresholds of 0.01-0.04 mA but in only 79% of patients with stimulus intensities of greater than 0.3 mA.

Neff et al have demonstrated that combining stimulus intensity with the amplitude of the induced response is a better predictor of HB grade at one year than either function alone.15

Prass has also indicated that he leaves the facial nerve monitor in position as the patient emerges from anesthesia.3,6 If voluntary facial nerve electromyographic activity can be identified during emergence, prognosis for a good long-term facial nerve outcome is excellent.

Multimedia

The surgical anatomy and landmarks of the facial ...Media file 1: The surgical anatomy and landmarks of the facial nerve.
The surgical anatomy and landmarks of the facial ...

The surgical anatomy and landmarks of the facial nerve.

Keywords

facial nerve monitors, facial nerve, facial, nerve, facial nerve injury, facial paralysis, intraoperative facial nerve monitoring, facial weakness, nerve monitors, nerve monitor, facial palsy

 


More on Monitors, Facial Nerve

References
Further Reading

References

  1. Chen L, Chen L, Liu L, Ling F, Yuan X, Fang J, et al. Vestibular schwannoma microsurgery with special reference to facial nerve preservation. Clin Neurol Neurosurg. Jan 2009;111(1):47-53. [Medline].

  2. Yingling CD, Gardi JN. Intraoperative monitoring of facial and cochlear nerves during acoustic neuroma surgery. 1992. Neurosurg Clin N Am. Apr 2008;19(2):289-315, vii. [Medline].

  3. Prass RL. Iatrogenic facial nerve injury: the role of facial nerve monitoring. Otolaryngol Clin North Am. Apr 1996;29(2):265-75. [Medline].

  4. Cai YR, Xu J, Chen LH, Chi FL. Electromyographic monitoring of facial nerve under different levels of neuromuscular blockade during middle ear microsurgery. Chin Med J (Engl). Feb 5 2009;122(3):311-4. [Medline].

  5. Huang BR, Chang CN, Hsu JC. Intraoperative electrophysiological monitoring in microvascular decompression for hemifacial spasm. J Clin Neurosci. Feb 2009;16(2):209-13. [Medline].

  6. Prass R, Luders H. Constant-current versus constant-voltage stimulation. J Neurosurg. Apr 1985;62(4):622-3. [Medline].

  7. Takashima K, Takahashi M, Yubune N, Inaba N, Omoto K, Kawano M, et al. [Evoked potential monitoring in an operation of neurosurgery]. Rinsho Byori. Jun 2008;56(6):475-85. [Medline].

  8. Hughes GB, Bottomy MB, Dickins JR, et al. A comparative study of neuropathologic changes following pulsed and direct current stimulation of the mouse sciatic nerve. Am J Otolaryngol. Nov 1980;1(5):378-84. [Medline].

  9. Babin RW, Ryu JH, McCabe BF. Responses to step and repeated impulse accelerations in second order vestibular neurons of the cat. Am J Otolaryngol. Nov 1980;1(5):385-92. [Medline].

  10. Selesnick SH. Optimal stimulus duration for intraoperative facial nerve monitoring. Laryngoscope. Sep 1999;109(9):1376-85. [Medline].

  11. Silverstein H, Willcox TO Jr, Rosenberg SI, Seidman MD. Prediction of facial nerve function following acoustic neuroma resection using intraoperative facial nerve stimulation. Laryngoscope. May 1994;104(5 Pt 1):539-44. [Medline].

  12. Ashram YA, Jackler RK, Pitts LH, Yingling CD. Intraoperative electrophysiologic identification of the nervus intermedius. Otol Neurotol. 2005;26(2):274-9. [Medline].

  13. Sobottka SB, Schackert G, May SA, et al. Intraoperative facial nerve monitoring (IFNM) predicts facial nerve outcome after resection of vestibular schwannoma. Acta Neurochir (Wien). 1998;140(3):235-42; discussion 242-3. [Medline].

  14. Bozord Grayeli A, Kalamarides M, Fraysse B, et al. Comparison between intraoperative observations and electromyographic monitoring data for facial nerve outcome after vestibular schwannoma surgery. Acta Otolaryngol. 2005;125(10):1069-74. [Medline].

  15. Neff BA, Ting J, Dickinson SL, Welling DB. Facial nerve monitoring parameters as a predictor of postoperative facial nerve outcomes after vestibular schwannoma resection. Otol Neurotol. 2005;26(4):728-32. [Medline].

  16. Beck DL, Atkins JS Jr, Benecke JE Jr, Brackmann DE. Intraoperative facial nerve monitoring: prognostic aspects during acoustic tumor removal. Otolaryngol Head Neck Surg. Jun 1991;104(6):780-2. [Medline].

  17. Blair EA, Teeple E Jr, Sutherland RM, et al. Effect of neuromuscular blockade on facial nerve monitoring. Am J Otol. Mar 1994;15(2):161-7. [Medline].

  18. Brauer M, Knuettgen D, Quester R, Doehn M. Electromyographic facial nerve monitoring during resection for acoustic neurinoma under moderate to profound levels of peripheral neuromuscular blockade. Eur J Anaesthesiol. Nov 1996;13(6):612-5. [Medline].

  19. Colletti V, Fiorino FG, Policante Z, Bruni L. New perspectives in intraoperative facial nerve monitoring with antidromic potentials. Am J Otol. Sep 1996;17(5):755-62. [Medline].

  20. Dulguerov P, Marchal F, Lehmann W. Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope. May 1999;109(5):754-62. [Medline].

  21. Esses BA, LaRouere MJ, Graham MD. Facial nerve outcome in acoustic tumor surgery. Am J Otol. Nov 1994;15(6):810-2. [Medline].

  22. Haenggeli A, Richter M, Lehmann W, Dulguerov P. A complication of intraoperative facial nerve monitoring: facial skin burns. Am J Otol. Sep 1999;20(5):679-82. [Medline].

  23. Jackler RK. A comparison of facial nerve monitoring systems in cerebellopontine angle surgery. Am J Otol. Jul 1991;12(4):312. [Medline].

  24. Kwartler JA, Luxford WM, Atkins J, Shelton C. Facial nerve monitoring in acoustic tumor surgery. Otolaryngol Head Neck Surg. Jun 1991;104(6):814-7. [Medline].

  25. Lenarz T, Ernst A. Intraoperative facial nerve monitoring in the surgery of cerebellopontine angle tumors: improved preservation of nerve function. ORL J Otorhinolaryngol Relat Spec. 1994;56(1):31-5. [Medline].

  26. Lennon RL, Hosking MP, Daube JR, Welna JO. Effect of partial neuromuscular blockade on intraoperative electromyography in patients undergoing resection of acoustic neuromas. Anesth Analg. Nov 1992;75(5):729-33. [Medline].

  27. Leonetti JP, Brackmann DE, Prass RL. Improved preservation of facial nerve function in the infratemporal approach to the skull base. Otolaryngol Head Neck Surg. Jul 1989;101(1):74-8. [Medline].

  28. Lowry TR, Gal TJ, Brennan JA. Patterns of use of facial nerve monitoring during parotid gland surgery. Otolaryngol Head Neck Surg. Sep 2005;133(3):313-8. [Medline].

  29. Magliulo G, Petti R, Vingolo GM, et al. Facial nerve monitoring in skull base surgery. J Laryngol Otol. Jul 1994;108(7):557-9. [Medline].

  30. Magliulo G, Zardo F. Intra-operative facial nerve monitoring. Its predictive value after skull base surgery. J Laryngol Otol. Aug 1997;111(8):715-8. [Medline].

  31. Nissen AJ, Sikand A, Curto FS, et al. Value of intraoperative threshold stimulus in predicting postoperative facial nerve function after acoustic tumor resection. Am J Otol. Mar 1997;18(2):249-51. [Medline].

  32. Olds MJ, Rowan PT, Isaacson JE, Silverstein H. Facial nerve monitoring among graduates of the Ear Research Foundation. Am J Otol. Jul 1997;18(4):507-11. [Medline].

  33. Pensak ML, Willging JP, Keith RW. Intraoperative facial nerve monitoring in chronic ear surgery: a resident training experience. Am J Otol. Jan 1994;15(1):108-10. [Medline].

  34. Roland PS, Meyerhoff WL. Intraoperative electrophysiological monitoring of the facial nerve: is it standard of practice?. Am J Otolaryngol. Jul-Aug 1994;15(4):267-70. [Medline].

  35. Sargent EW, Beck DL. Facial nerve monitoring. Laryngoscope. Sep 1995;105(9 Pt 1):1017-8. [Medline].

  36. Zeitouni AG, Hammerschlag PE, Cohen NL. Prognostic significance of intraoperative facial nerve stimulus thresholds. Am J Otol. Jul 1997;18(4):494-7. [Medline].

Further Reading

Clinical guidelines

Stereotactic radiosurgery for patients with vestibular schwannomas.
IRSA - Professional Association. 2006 May. 16 pages. NGC:004981

Head (trauma, headaches, etc., not including stress & mental disorders).
Work Loss Data Institute - Public For Profit Organization. 2006 (revised 2008 Apr 21). 152 pages. NGC:006558

Clinical trial

Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery

Related eMedicine topics

Facial Nerve Paralysis

Facial Nerve Paralysis, Dynamic Reconstruction

Nerve Block, Oral

Skull Base, Petrous Apex, Tumors

Keywords

facial nerve monitors, facial nerve, facial, nerve, facial nerve injury, facial paralysis, intraoperative facial nerve monitoring, facial weakness, nerve monitors, nerve monitor, facial palsy

Contributor Information and Disclosures

Author

Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development
Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Alcon labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear corp Honoraria Board membership; Med El corp travel grants Consulting

Medical Editor

Gregory Branham, MD, Vice-Chair, Director, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, Saint Louis University School of Medicine
Gregory Branham, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Physician Executives, and Missouri State Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

David W Stepnick, MD, Associate Professor, Departments of Plastic Surgery and Otolaryngology-Head and Neck Surgery, Case Western Reserve University School of Medicine, University Hospitals of Cleveland Case Medical Center
David W Stepnick, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society for Head and Neck Surgery, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.